Equities

Calmer Co International Ltd

Calmer Co International Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.008
  • Today's Change-0.001 / -11.11%
  • Shares traded784.00k
  • 1 Year change+117.98%
  • Beta1.8930
Data delayed at least 20 minutes, as of Nov 11 2024 04:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Calmer Co. International Limited is a health and wellness company with operations in Australia, Fiji, and the USA. The Company produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery and performance. The company works with farmers to source high quality kava and hemp that is processed into active extracts for business to business (B2B) sales or into finished products across a house of brands. The Company’s brands include Fiji Kava, Taki Mai, and Danodan Hempworks. Its Taki Mai and Fiji Kava brands are focused on expanding the distribution of kava throughout global markets to provide a natural alternative to alcohol and to small molecule sleep and antianxiety prescription medicines. Its Danodan brand offers a patented range of USDA certified organic tinctures, and soon topicals, sold throughout the USA and online for relaxation, sleep, and recovery.

  • Revenue in AUD (TTM)4.26m
  • Net income in AUD-3.73m
  • Incorporated2014
  • Employees--
  • Location
    Calmer Co International Ltd96 Victoria Street, West EndBRISBANE 4101AustraliaAUS
  • Phone+61 86489-1600
  • Fax+61 86489-1601
  • Websitehttps://www.thecalmerco.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CCO:ASX since
announced
Transaction
value
Kaiming Agro Processing Ltd-Navua Processing FacilityAnnounced09 Oct 202409 Oct 2024Announced-20.00%1.95m
Data delayed at least 20 minutes, as of Nov 11 2024 04:58 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hydration Pharmaceuticals Co Ltd14.53m-11.50m5.18m--------0.3568-0.0459-0.04590.0546-0.01361.491.566.38---117.74-79.98-251.39-111.5756.0048.73-79.18-99.530.8282-4.392.42--10.3419.2723.61------
Nutritional Growth Solutions Ltd4.06m-4.03m5.56m--------1.37-0.1668-0.16680.1677-0.08542.082.3633.46---206.84------22.3642.47-99.30-152.300.0943-57.50----1.2641.6131.91------
Epsilon Healthcare Ltd7.21m-5.93m7.21m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
TrivarX Ltd893.31k-1.43m8.23m4.00--0.7453--9.21-0.0045-0.00450.00270.02420.0935-------15.02-37.57-17.67-43.65100.0092.56-160.59-446.23---105.740.0016---6.99-26.3953.28--17.61--
Anatara Lifesciences Ltd0.00-1.45m11.96m----8.68-----0.0098-0.00980.000.00710.00-------93.91-76.37-126.61-88.90------------0.00------28.27------
Firebrick Pharma Ltd14.52k-1.18m11.98m----4.75--824.81-0.0066-0.00660.000080.0120.0054--0.0267---43.64-98.70-51.22-109.33-156.89---8,098.28-80,697.286.36--0.00--1,649.40--82.71------
Acrux Ltd8.10m-5.80m14.25m43.00--4.35--1.76-0.02-0.020.0280.01130.728--2.61---52.14-45.05-71.89-54.0451.14---71.62-114.01----0.5307---32.118.91-659.16---6.20--
Argent BioPharma Ltd891.08k-17.53m15.74m--------17.66-0.5116-0.51160.0241-0.11380.08580.61441.77---168.97-129.61---254.2822.86-27.15-1,969.34-667.990.1532-37.54-----73.706.3115.81---17.96--
Immuron Ltd4.90m-6.94m17.64m6.00--1.38--3.60-0.0304-0.03040.02150.05570.26121.295.43---36.96-27.01-42.53-29.3368.0674.23-141.49-245.534.87-3.030.0032--171.6715.48-83.20---37.22--
Althea Group Holdings Ltd30.37m-32.06m17.83m----56.96--0.5872-0.0858-0.08580.08080.00080.84382.347.03---89.06-37.78-167.97-47.1360.7053.83-105.54-94.470.4086-4.080.9466--20.8799.01-133.57---25.27--
Calmer Co International Ltd4.26m-3.73m19.81m--------4.65-0.0035-0.00350.0038-0.00031.132.019.14---98.45-119.20-395.42-195.4949.6239.01-87.42-219.690.5607-12.301.27--138.9287.7928.91---20.42--
Nyrada Inc3.40m-1.39m23.06m----3.97--6.78-0.0081-0.00810.02090.02770.6147-------25.13-53.28-29.75-62.52-----40.89-236.15----0.00--115.5546.4282.12------
Data as of Nov 11 2024. Currency figures normalised to Calmer Co International Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.